Raphael J. Mannino
Keine laufenden Positionen mehr
Karriereverlauf von Raphael J. Mannino
Ehemalige bekannte Positionen von Raphael J. Mannino
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MATINAS BIOPHARMA HOLDINGS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2015 | 11.08.2022 |
University of Medicine & Dentistry of New Jersey | Corporate Officer/Principal | 01.01.1990 | 01.08.2015 |
BIODELIVERY SCIENCES INTERNATIONAL, INC. | Direktor/Vorstandsmitglied | 01.01.2000 | 01.01.2007 |
Technik-/Wissenschafts-/F&E-Leiter | 01.01.2001 | 01.01.2009 | |
Gründer | 01.01.1995 | 01.01.2009 | |
Albany Medical College | Corporate Officer/Principal | 01.01.1980 | 01.01.1990 |
New Jersey Medical School | Corporate Officer/Principal | 01.01.1980 | 01.01.1980 |
BioVest International, Inc.
BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | Direktor/Vorstandsmitglied | 01.06.2003 | - |
Independent Dir/Board Member | 01.06.2003 | - |
Ausbildung von Raphael J. Mannino
The Johns Hopkins University School of Medicine | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 7 |
2 |
Operativ
Corporate Officer/Principal | 3 |
Director/Board Member | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Sektoral
Consumer Services | 5 |
Health Technology | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
MATINAS BIOPHARMA HOLDINGS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
BioVest International, Inc.
BioVest International, Inc. Medical SpecialtiesHealth Technology BioVest International, Inc. develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers. The firm continued development, commercialization, manufacture and sale of AutovaxID and other instruments and disposables; and the commercial sale and production of cell culture products and services. The company was founded in 1981 and is headquartered in Tampa, FL. | Health Technology |
BioDelivery Sciences International, Inc.
BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC. | Health Technology |
- Börse
- Insiders
- Raphael J. Mannino
- Erfahrung